Ciołek Lidia, Krok-Borkowicz Małgorzata, Gąsiński Arkadiusz, Biernat Monika, Antosik Agnieszka, Pamuła Elżbieta
Biomaterials Research Group, Łukasiewicz Research Network-Institute of Ceramic and Building Materials, 31-983 Kraków, Poland.
Department of Biomaterials and Composites, Faculty of Materials Science and Ceramics, AGH University of Science and Technology, Al. Mickiewicza 30, 30-059 Kraków, Poland.
Polymers (Basel). 2023 Oct 4;15(19):3994. doi: 10.3390/polym15193994.
The development of innovative biomaterials with improved integration with bone tissue and stimulating regeneration processes is necessary. Here, we evaluate the usefulness of bioactive glasses from the SiO-PO-CaO system enriched with 2 wt.% SrO or ZnO in the manufacturing of chitosan-based scaffolds. Bioglasses produced using the sol-gel method were subjected to thermal treatment in different regimes. Chitosan/bioglass composites were produced with a weight ratio. Bioglasses were evaluated via TG-DTA, FTIR, and SEM-EDS before and after incubation in simulated body fluid (SBF). The release of ions was tested. The cytocompatibility of the composites in contact with MG63 osteoblast-like cells was evaluated. The results showed that the presence of the crystalline phase decreased from 41.2-44.8% for nonmodified bioglasses to 24.2-24.3% for those modified with ZnO and 22.0-24.2% for those modified with SrO. The samples released Ca, Zn, and/or Sr ions and were bioactive according to the SBF test. The highest cytocompatibility was observed for the composites containing nonmodified bioglasses, followed by those enriched with SrO bioglasses. The least cytocompatible were the composites containing ZnO bioglasses that released the highest amount of Zn ions (0.58 ± 0.07 mL/g); however, those that released 0.38 ± 0.04 mL/g were characterised by acceptable cytocompatibility. The study confirmed that it is feasible to control the biological performance of chitosan/bioglass composites by adjusting the composition and heat treatment parameters of bioglasses.
开发与骨组织具有更好整合性并能刺激再生过程的创新生物材料是必要的。在此,我们评估了富含2 wt.% SrO或ZnO的SiO-PO-CaO体系生物活性玻璃在壳聚糖基支架制造中的实用性。采用溶胶-凝胶法制备的生物玻璃在不同条件下进行了热处理。以重量比制备了壳聚糖/生物玻璃复合材料。在模拟体液(SBF)中孵育前后,通过TG-DTA、FTIR和SEM-EDS对生物玻璃进行了评估。测试了离子的释放情况。评估了复合材料与MG63成骨样细胞接触时的细胞相容性。结果表明,结晶相的存在从未改性生物玻璃的41.2 - 44.8%降至用ZnO改性的生物玻璃的24.2 - 24.3%以及用SrO改性的生物玻璃的22.